Doctors Note Logo

Published on: 10/1/2026

Can ulcerative colitis be cured, and how long remission lasts

Ulcerative colitis currently has no medical cure, but surgery to remove the colon can eliminate the disease, and medications often produce long stretches of remission. Remission length varies widely, from a few months to many years, with studies suggesting about half of people relapse within a year while others stay symptom free for decades. Several factors shape that outcome, including medication adherence, the extent and severity of inflammation, infections, NSAID use, and stress, and important details are explained below.

Because flares can begin subtly with changes in stool frequency, urgency, blood, fatigue, or abdominal pain, tracking symptoms early can make a real difference in how quickly treatment is adjusted. Take a free, instant, online symptom check to better understand what your current symptoms may mean and what steps to consider next.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

Can Ulcerative Colitis Be Cured?

Ulcerative colitis (UC) is a chronic inflammatory condition of the colon and rectum. It causes symptoms such as abdominal pain, diarrhea, bleeding, fatigue and weight loss. Because UC is a lifelong condition, many patients ask: can ulcerative colitis be cured? While there is no definitive cure for UC at this time, advances in treatment allow most people to achieve and maintain remission—periods with few or no symptoms. Remission length varies from person to person, depending on disease severity, treatment choices and lifestyle factors.


Why There’s No Absolute Cure (Yet)

  • UC is an autoimmune condition. Your immune system mistakenly attacks the lining of the colon, causing inflammation.
  • Researchers continue to explore genetic, environmental and microbiome factors that trigger UC.
  • Though we don’t fully understand what starts or stops UC, we have many therapies to control it and prevent complications.

Because the underlying cause remains unclear, no treatment “fixes” the immune system permanently. Instead, doctors focus on controlling inflammation, healing the gut lining and minimizing side effects.


Treatment Goals

  1. Induce remission — get you into a symptom-free or low-symptom state.
  2. Maintain remission — keep the disease quiet over the long term.
  3. Prevent complications — such as strictures, colon cancer or severe bleeding.
  4. Improve quality of life — let you take part in work, school or social activities.

Main Treatments for Remission

Treatment choice depends on disease extent (proctitis vs. left-sided vs. pancolitis), severity (mild, moderate, severe) and your overall health.

1. 5-Aminosalicylic Acids (5-ASAs)

  • Examples: mesalamine, sulfasalazine
  • How they work: Reduce inflammation in the colon lining
  • Use: First-line for mild to moderate UC
  • Side effects: Headache, nausea, rare kidney effects

2. Corticosteroids

  • Examples: prednisone, budesonide
  • How they work: Powerful anti-inflammatory action
  • Use: Short-term induction of remission when symptoms are moderate to severe
  • Side effects: Weight gain, mood swings, high blood sugar—so doctors taper off quickly

3. Immunomodulators

  • Examples: azathioprine, 6-mercaptopurine, methotrexate
  • How they work: Quiet the immune response over time
  • Use: Maintain remission, steroid-sparing
  • Side effects: Increased infection risk, liver enzyme changes

4. Biologics

  • Examples: infliximab, adalimumab, vedolizumab, ustekinumab
  • How they work: Target specific immune molecules (TNF, integrins, interleukins)
  • Use: Moderate to severe UC, especially when other meds fail
  • Side effects: Infusion reactions, infection risk (including TB)

5. Small Molecule Drugs

  • Examples: tofacitinib, ozanimod
  • How they work: Block inflammatory signaling inside cells
  • Use: Moderate to severe UC after biologics or when rapid oral therapy is needed
  • Side effects: Blood clots, infections, lipid changes

Surgery: A Potential “Cure”?

Surgical removal of the colon (colectomy) essentially eliminates UC in the bowel. The most common procedure is proctocolectomy with ileal pouch–anal anastomosis (IPAA).

  • Pros
    – No more colitis or need for long-term anti-inflammatory drugs
    – Improved quality of life for many
  • Cons
    – Pouchitis (inflammation of the new pouch) in 20–50% of patients
    – Changes in bowel habits (more frequent, urgent stools)
    – Rare pouch failure requiring further surgery

While colectomy can be considered a cure of colonic inflammation, it’s not without lifelong considerations. Discuss risks and benefits carefully with a colorectal surgeon if medications cannot control your UC.


How Long Does Remission Last?

Remission duration varies widely. Factors include:

  • Disease extent and initial severity
  • How early treatment began
  • Choice and combination of medications
  • Adherence to therapy and follow-up
  • Lifestyle factors (diet, smoking, stress)

Typical Remission Statistics

  • 50–70% of patients achieve remission within 8–12 weeks of starting first-line therapy.
  • About 20–30% of mild cases maintain drug-free remission after one year.
  • Biologics and immunomodulators can extend remission to 1–2 years or longer for many patients.
  • After discontinuing steroids, up to 50% may relapse within six months without maintenance therapy.

Individual experiences vary. Some people stay symptom-free for years on the right regimen. Others need treatment adjustments more frequently.


Tips to Maximize and Prolong Remission

  1. Medication Adherence
    – Take meds exactly as prescribed.
    – Report side effects promptly—your doctor can adjust doses or switch therapies.
  2. Regular Monitoring
    – Colonoscopy schedules to screen for dysplasia or cancer.
    – Blood tests for drug levels, liver and kidney function.
  3. Diet and Nutrition
    – No single “UC diet,” but try a balanced, anti-inflammatory eating pattern.
    – Work with a dietitian if you have nutrient deficiencies.
  4. Stress Management
    – Stress can worsen UC flares.
    – Techniques: yoga, meditation, counseling, exercise.
  5. Smoking Status
    – Unlike Crohn’s disease, smoking seems to improve UC in some.
    – However, smoking has many health risks. Discuss with your doctor before making any changes.
  6. Vaccinations
    – Keep up to date on flu, pneumonia and other vaccines—especially if on immunosuppressants.
  7. Lifestyle Factors
    – Aim for regular sleep, moderate exercise and a strong support network.

When to Seek Help

Even in remission, watch for:

  • New or worsening abdominal pain
  • Increased stool frequency or bleeding
  • Fever or unexplained weight loss
  • Joint pain, eye redness or mouth sores (extraintestinal symptoms)
  • Signs of complications: severe dehydration, vomiting or chest pain

If you notice any of these, please speak to your doctor right away.


Track Your Symptoms Online

Not sure whether your symptoms are UC-related? You can try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.


Final Thoughts

  • There is no absolute cure for ulcerative colitis at present.
  • Most people can achieve and maintain remission with medications, lifestyle changes and regular medical care.
  • Surgery can remove the disease but carries its own risks and lifestyle considerations.
  • Remission length varies—some stay symptom-free for years, others need treatment tweaks more often.
  • Always work closely with your gastroenterologist and care team to adjust therapy and monitor for complications.

If you experience any life-threatening or serious symptoms—such as severe bleeding, high fever or signs of dehydration—please speak to a doctor or go to the nearest emergency department immediately.

(References)

  • * Jackson EL, Hamlin PJ, Ford AC. VSL#3 and remission in active ulcerative colitis: larger studies required. Am J Gastroenterol. 2011 Mar;106(3):547; author reply 547-8. doi: 10.1038/ajg.2010.451. PMID: 21378771.

  • * He HH, Shen H, Gu PQ. [Prevention and treatment on remission of ulcerative colitis]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Feb;31(2):280-6. PMID: 21425592.

  • * Shimizu H, Arai K, Abe J, Nakabayashi K, Yoshioka T, Hosoi K, Kuroda M. Repeated fecal microbiota transplantation in a child with ulcerative colitis. Pediatr Int. 2016 Aug;58(8):781-5. doi: 10.1111/ped.12967. Epub 2016 Jun 21. PMID: 27324973.

  • * Velegraki M, Flamourakis M, Kazamias G, Georgiou G, Karmiris K. Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious. Inflamm Bowel Dis. 2019 Sep 18;25(10):e123-e124. doi: 10.1093/ibd/izz152. PMID: 31301172.

  • * Kuwabara S, Tanimura S, Matsumoto S, Nakamura H, Horita T. Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis. Ann Rheum Dis. 2020 Aug;79(8):1125-1126. doi: 10.1136/annrheumdis-2019-216606. Epub 2020 Mar 25. PMID: 32213500.

  • * de Sire R, Castiglione F, Picardi M, Mascolo M, Di Luna I, Corcione F, D'Ambra M, Travaglino A, Rispo A. Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma. Inflamm Bowel Dis. 2021 Jun 15;27(7):e81-e82. doi: 10.1093/ibd/izab010. PMID: 33501977.

  • * Lopes SR, Martins C, Teixeira M, Tomás D. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis. World J Gastroenterol. 2024 Sep 14;30(34):3929-3931. doi: 10.3748/wjg.v30.i34.3929. PMID: 39350781; PMCID: PMC11438653.

  • * Pedicelli A, Afif W. In active ulcerative colitis, risankizumab induced and maintained remission. Ann Intern Med. 2024 Nov;177(11):JC127. doi: 10.7326/ANNALS-24-02768-JC. Epub 2024 Nov 5. PMID: 39496179.

  • * Molander P, Af Björkesten CG, Henricson H, Koskela R, Nuutinen H, Käräjämäki A, Tillonen J, Tauriainen MM, Kellokumpu M, Eronen H, Suhonen UM, Vihriälä I, Hallinen T, Oksanen M, Soini E, Koivunen M, Kuronen M, Wirth D, Sipponen T. Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study. Eur J Gastroenterol Hepatol. 2025 Apr 1;37(4):446-453. doi: 10.1097/MEG.0000000000002939. Epub 2025 Feb 5. PMID: 39970041; PMCID: PMC11867796.

  • * Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A, Italian Network for Inflammatory Bowel Diseases (IN-IBD). Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study. Adv Ther. 2026 Jul;43(7):3165-3186. doi: 10.1007/s12325-026-03622-3. Epub 2026 May 9. PMID: 42105145; PMCID: PMC13290896.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.